| Literature DB >> 21849053 |
Magdalena Serrano1, Natalia Moreno-Sánchez, Carmen González, Ane Marcos-Carcavilla, Mario Van Poucke, Jorge H Calvo, Judit Salces, Jaime Cubero, María J Carabaño.
Abstract
BACKGROUND: Reference genes with stable expression are required to normalize expression differences of target genes in qPCR experiments. Several procedures and companion software have been proposed to find the most stable genes. Model based procedures are attractive because they provide a solid statistical framework. NormFinder, a widely used software, uses a model based method. The pairwise comparison procedure implemented in GeNorm is a simpler procedure but one of the most extensively used. In the present work a statistical approach based in Maximum Likelihood estimation under mixed models was tested and compared with NormFinder and geNorm softwares. Sixteen candidate genes were tested in whole blood samples from control and heat stressed sheep.Entities:
Mesh:
Year: 2011 PMID: 21849053 PMCID: PMC3175163 DOI: 10.1186/1471-2199-12-36
Source DB: PubMed Journal: BMC Mol Biol ISSN: 1471-2199 Impact factor: 2.946
Figure 1Distribution of Cycle threshold (Cq) values for the candidate reference genes. Distribution of Cycle threshold (Cq) values for the candidate reference genes (n = 29 samples) obtained by qPCR. Data of the three replicates per sample were averaged and those of the two thermal treatments were pooled for each gene. Boxes show the range of Cq values within each gene; the centre line indicates de median; extended vertical bars show standard deviation of the mean.
Estimated gene amplification efficiencies
| Gene | slope | Efficiency | correlation |
|---|---|---|---|
| -3.593 | 1.90 | 1.000 | |
| -3.377 | 1.98 | 0.995 | |
| -3.701 | 1.86 | 0.999 | |
| -3.701 | 1.86 | 0.999 | |
| -3.661 | 1.88 | 0.999 | |
| -3.730 | 1.85 | 0.856 | |
| -3.598 | 1.90 | 0.998 | |
| -3.648 | 1.88 | 0.842 | |
| -3.775 | 1.84 | 0.993 | |
| -3.624 | 1.89 | 0.995 | |
| - | 1.99 | 0.997 | |
| -3.727 | 1.85 | 0.998 | |
| -4.020 | 1.77 | 0.996 | |
| -4.161 | 1.74 | 0.997 | |
| -4.033 | 1.77 | 0.996 | |
| -4.138 | 1.74 | 0.996 | |
Goodness of fit and predictive ability criterion of the tested ML-mixed models
| MID | n° parameters | -2LogL | AIC | BIC | BIC(%) | PD | PD(%) |
|---|---|---|---|---|---|---|---|
| 1 | 5 | -3141.0 | -3097.0 | -3081.4 | 87.67 | 0.001233 | 52.67 |
| 2 | 20 | -3460.4 | -3386.4 | -3360.2 | 95.60 | 0.001230 | 52.54 |
| 3 | 36 | -3658.2 | -3552.2 | -3514.7 | 100 | 0.001408 | 60.14 |
| 4 | 19 | -3156.9 | -3084.9 | -3059.5 | 87.04 | 0.002027 | 86.58 |
| 5 | 35 | -3203.0 | -3099.0 | -3062.2 | 87.12 | 0.002020 | 86.28 |
| 6 | 19 | -3016.5 | -2944.5 | -2919.1 | 83.05 | 0.001827 | 78.04 |
| 7 | 35 | -3308.0 | -3204.0 | -3167.2 | 90.11 | 0.002341 | 100 |
| 8 | 32 | -3476.8 | -3296.8 | -3164.9 | 90.04 | 0.002084 | 89.02 |
MID = model identification, -2LogL = -2 log of the likelihood function (smaller is better), AIC = Akaike Information Criterion (smaller is better), BIC = Bayes Information Criterion (smaller is better), BIC(%) = percentage of fit (higher is better), PD = predictive ability criterion (smaller is better), PD(%) = percentage of predictive ability loss (smaller is better)
ML-Mixed models description
| MID | Model | Variance structure | n° (co)variance parameters |
|---|---|---|---|
| 1 | yijk = μ + ti + gj + ak + tgij + taik + gajk + eijk | a~N(0,σ2a); tg~N(0,σ2tg); ta~N(0,σ2ta); ga~N(0,σ2ga); e~N(0,σ2e) | 5 |
| 2 | yijk = μ + ti + gj + ak + tgij + taik + gajk + eijk | a~N(0,σ2a); tg~N(0,σ2tg); ta~N(0,σ2ta); ga~N(0,σ2ga); e~N(0,σ2ej) | 20 |
| 3 | yijk = μ + ti + gj + ak + tgij + taik + gajk + eijk | a~N(0,σ2a); tg~N(0,σ2tg); ta~N(0,σ2ta); ga~N(0,σ2ga); e~N(0,σ2eij) | 36 |
| 4 | yijk = μ + ti + gj + ak + tgij + taik + eijk | a~N(0,σ2a); tg~N(0,σ2tg); ta~N(0,σ2ta); e~N(0,σ2ej) | 19 |
| 5 | yijk = μ + ti + gj + ak + tgij + taik + eijk | a~N(0,σ2a); tg~N(0,σ2tg); ta~N(0,σ2ta); e~N(0,σ2eij) | 35 |
| 6 | yijk = μ + ti + gj + ak + tgij + gaik + eijk | a~N(0,σ2a); tg~N(0,σ2tg); ga~N(0,σ2ga); e~N(0,σ2ej) | 19 |
| 7 | yijk = μ + ti + gj + ak + tgij + gaik + eijk | a~N(0,σ2a); tg~N(0,σ2tg); ga~N(0,σ2ga); e~N(0,σ2eij) | 35 |
| 8 | yijk = μ + tgij + taik + eijk | e~N(0,σ2eij) | 32 |
In the Model column the fixed effects were t = treatment (2 levels) and g = gene (16 levels); the random effects were a = sample (15 levels), tg = interaction treatment × gene (32 levels), ta = interaction treatment × sample (29 levels), ga = interaction gene × sample (240 levels), and e = residual. Residual variances: σ2e = homoskedastic residuals and σ2ej = heteroskedastic residual for the gene effect (16 residual variances); σ2eij = heteroskedastic residual for the treatment × gene effect (32 residual variances). Model 8 was proposed by Andersen et al [5], where txg y txa interactions are treated as fixed effects.
MID - model identification
Estimates of bias, variances and MSE of candidate reference genes obtained by fitting ML-mixed model 3
| Gene | Variance | Variance | MSE | MSE | MSE | |
|---|---|---|---|---|---|---|
| Bias | Control | Heat stress | Control | Heat stress | max | |
| 0.00652 | 0.00063 | 0.00002 | 0.00067 | 0.00006 | 0.00067 | |
| 0.01708 | 0.00059 | 0.00006 | 0.00088 | 0.00035 | 0.00088 | |
| -0.01632 | 0.00006 | 0.00087 | 0.00033 | 0.00114 | 0.00114 | |
| 0.00753 | 0.00008 | 0.00143 | 0.00014 | 0.00148 | 0.00148 | |
| -0.02230 | 0.00118 | 0.00002 | 0.00168 | 0.00052 | 0.00168 | |
| 0.03549 | 0.00065 | 0.00009 | 0.00191 | 0.00135 | 0.00191 | |
| -0.01932 | 0.00158 | 0.00069 | 0.00196 | 0.00106 | 0.00196 | |
| 0.04607 | 0.00060 | 0.00007 | 0.00272 | 0.00219 | 0.00272 | |
| -0.02412 | 0.00243 | 0.00002 | 0.00302 | 0.00060 | 0.00302 | |
| -0.04385 | 0.00010 | 0.00139 | 0.00203 | 0.00331 | 0.00331 | |
| -0.01210 | 0.00009 | 0.00362 | 0.00023 | 0.00377 | 0.00377 | |
| 0.05618 | 0.00002 | 0.00073 | 0.00318 | 0.00389 | 0.00389 | |
| 0.06370 | 0.00163 | 0.00004 | 0.00569 | 0.00410 | 0.00569 | |
| -0.02738 | 0.00188 | 0.00553 | 0.00263 | 0.00628 | 0.00628 | |
| -0.02782 | 0.00613 | 0.00409 | 0.00691 | 0.00486 | 0.00691 | |
| -0.03935 | 0.00005 | 0.00628 | 0.00160 | 0.00783 | 0.00783 | |
Bias of the control samples. Estimates of bias of the heat-stress samples were the same as for control but with opposite sign.
Ranking of genes based on ML-mixed model 3, NormFinder and geNorm approaches.
| Ranking position | gene | ML-Mixed model 3 | gene | NormFinder | gene | geNorm |
|---|---|---|---|---|---|---|
| best pair | RPS26/SDHA | 0.0005 | RPS26/YWHAB | 0.008 | ACTB/RPL13A | 0.294 |
| 1 | RPS18 | 0.0007 | RPS18 | 0.013 | YWHAB | 0.782 |
| 2 | RPS26 | 0.0009 | B2M | 0.022 | RPS18 | 0.790 |
| 3 | SDHA | 0.0011 | YWHAZ | 0.024 | ACTB | 0.796 |
| 4 | B2M | 0.0015 | SDHA | 0.026 | SDHA | 0.797 |
| 5 | ACTB | 0.0017 | YWHAB | 0.029 | B2M | 0.815 |
| 6 | MDH1 | 0.0019 | RPS26 | 0.030 | YWHAZ | 0.833 |
| 7 | YWHAZ | 0.0020 | ACTB | 0.035 | RPL13A | 0.839 |
| 8 | LOC780524 | 0.0027 | CYP1A1 | 0.037 | RPS26 | 0.847 |
| 9 | GAPDH | 0.0030 | GAPDH | 0.039 | GAPDH | 0.882 |
| 10 | YWHAB | 0.0033 | RPL13A | 0.043 | RPLP0 | 0.899 |
| 11 | RPLP0 | 0.0038 | MDH1 | 0.048 | LOC780524 | 1.085 |
| 12 | RPL19 | 0.0039 | ACACA | 0.057 | MDH1 | 1.119 |
| 13 | ATP5G2 | 0.0057 | RPLP0 | 0.058 | RPL19 | 1.140 |
| 14 | CYP1A1 | 0.0063 | LOC780524 | 0.061 | CYP1A1 | 1.170 |
| 15 | ACACA | 0.0069 | RPL19 | 0.072 | ATP5G2 | 1.308 |
| 16 | RPL13A | 0.0078 | ATP5G2 | 0.077 | ACACA | 1.568 |
Figure 2Comparison between NormFinder and ML-mixed model. Comparison between NormFinder and ML-mixed model 3 estimates of inter- and intra-group variability. Inter-group variation is represented in the Y axes. Intra-group variation (bias from our ML-mixed model procedure and intra-group standard deviations from the NormFinder one) is presented as error bars on estimates of the inter-group differences for each gene. Downward dotted bars correspond to NormFinder estimates and upward solid bars to ML-mixed model 3.
Average MSE of the best genes combination for sets from 2 to 7 genes tested under ML-mixed model 3
| Gene | Average | ||||||
|---|---|---|---|---|---|---|---|
| 2 | RPS26 | SDHA | 0.00047 | ||||
| 120* | RPS18 | SDHA | 0.00047 | ||||
| MDH1 | SDHA | 0.00057 | |||||
| B2M | ACTB | 0.00077 | |||||
| MDH1 | ACTB | 0.00096 | |||||
| SDHA | ACTB | 0.00099 | |||||
| B2M | SDHA | 0.00116 | |||||
| B2M | MDH1 | 0.00122 | |||||
| 3 | RPS18 | RPS26 | SDHA | 0.00043 | |||
| 560 | RPS18 | LOC780524 | YWHAB | 0.00050 | |||
| RPS18 | MDH1 | YWHAB | 0.00050 | ||||
| RPL19 | ACTB | SDHA | 0.00057 | ||||
| MDH1 | SDHA | ACTB | 0.00063 | ||||
| MDH1 | B2M | ACTB | 0.00068 | ||||
| MDH1 | SDHA | B2M | 0.00087 | ||||
| SDHA | ACTB | B2M | 0.00088 | ||||
| 4 | RPS18 | RPS26 | MDH1 | YWHAB | 0.00051 | ||
| 1,820 | RPS18 | RPL19 | ACTB | SDHA | 0.00051 | ||
| RPS18 | RPS26 | LOC780524 | YWHAB | 0.00052 | |||
| 5 | RPS18 | RPS26 | LOC780524 | SDHA | YWHAB | 0.00048 | |
| 4,368 | RPS18 | RPS26 | MDH1 | SDHA | YWHAB | 0.00049 | |
| RPS18 | RPS26 | B2M | ACTB | SDHA | 0.00051 | ||
| 6 | RPS18 | RPS26 | MDH1 | LOC780524 | SDHA | YWHAB | 0.00049 |
| 8,008 | RPS18 | RPS26 | RPL19 | ACTB | SDHA | YWHAB | 0.00052 |
| RPS18 | MDH1 | RPL19 | ACTB | SDHA | YWHAB | 0.00053 | |
| 7 | RPS18 | RPS26 | MDH1 | RPL19 | ACTB | SDHA | 0.00048 |
| 11,440 | RPS18 | RPS26 | LOC780524 | RPL19 | ACTB | SDHA | 0.00049 |
| RPS18 | MDH1 | LOC780524 | RPL19 | ACTB | SDHA | 0.00054 | |
| All genes | 0.00156 | ||||||
*Under each set number (from 2 to 7) the number of possible combinations appears.
Tested candidate reference genes
| Gene symbol | Gene full name | Gene ID | GO |
|---|---|---|---|
| Ribosomal protein S18 | 100036761 | Translation | |
| Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide | 780452 | mRNA metabolic process | |
| Acetyl-CoA carboxilase | 443186 | Lipid process | |
| Ribosomal protein S26 | 443468 | Translation | |
| Beta-2 microglobulin | 443295 | Immune response | |
| Malate dehydrogenase | 443091 | Glycolysis | |
| Ribosomal protein S2 (RPS2) | 780524 | Translation | |
| Ribosomal protein L19 | 100270789 | Translation | |
| ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9) | 443542 | Ion transport | |
| Glyceraldehyde 3-phosphate dehydrogenase | 443005 | Glycolysis | |
| Cytochrome P4501A1 | 100170113 | Oxidation-reduction process | |
| Actin beta | 443052 | Cellular component movement | |
| Ribosomal protein L13a | 100036760 | Translation | |
| Ribosomal protein large P0 | 100036764 | Translation | |
| Succinate dehydrogenase complex, subunit A, flavoprotein | 100036762 | Oxidation-reduction process | |
| Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta polypeptide | 100036763 | Protein targeting | |